From the *MedStar Washington Hospital Center, Washington, DC;
†National Institute of Nursing Research, Bethesda, MD;
‡Fred Hutchinson Cancer Research Center, Seattle, WA;
§National Institute of Environmental Health Science, Research Triangle Park, NC; and
∥Medstar Health Research Institute and Georgetown/Howard Universities Center for Clinical and Translational Sciences, Washington, DC.
The Women's Health Initiative (WHI) program is funded by the National Heart, Lung, and Blood Institute, National Institutes of Health, and the US Department of Health and Human Services, through contracts HHSN268201600018C, HHSN268201600001C, HHSN268201600002C, HHSN268201600003C, and HHSN268201600004C.
This research was supported (in part) by the intramural research program of the National Institutes of Health, National Institute of Nursing Research.
All participants provided written informed consent. Institutional review board (IRB) approval was obtained from each of the participating study centers and from the Fred Hutchinson Cancer Research Center, which currently serves as the IRB of record for the WHI. Federalwide assurance number is 00001920, and the registration numbers for each of the IRBs are as follows: Fred Hutchinson Cancer Research Center IRB registration no. Com A (00000021), Com B (00000022), Com C (00005619), Com D (00009831). The original protocol and consents were approved by all 40 IRBs of the participating WHI sites.
The authors declare no conflict of interest.
Correspondence: Diman Lamichhane, MD, Division of Rheumatology, MedStar Washington Hospital Center, 110 Irving St NW, Washington, DC 20010. E-mail: [email protected].
